VI Partners — 2015 Investments

1 investments dated 2015 · listed companies and verified rows first · show all

JenaValvejenavalve.comJul 2015

JenaValve manufactures the Trilogy Transcatheter Heart Valve System, an FDA-approved device for treating severe aortic regurgitation in high-risk patients who cannot undergo surgical valve replacement.

HealthtechMedical DevicesIrvine, US

Victoria Carr-Brendel(Executive Officer, Director)Hans-Reiner Figulla(Director)David Drachman(Executive Officer, Director)

BoardErik Amble(Director)Peter Barrett(Director)

Board seatArnd Kaltofen· per SEC Form D

Co-investorsAndera Partners Bain Capital Life Sciences

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.